PURPOSE: To determine the association between dark adaption (DA) and different health conditions linked with age-related macular degeneration (AMD). METHODS: Cross-sectional study, including patients with AMD and a control group. Age-related macular degeneration was graded according to the Age-Related Eye Disease Study (AREDS) classification. We obtained data on medical history, medications, and lifestyle. Dark adaption was assessed with the extended protocol (20 minutes) of AdaptDx (MacuLogix). For analyses, the right eye or the eye with more advanced AMD was selected. Multivariate linear and logistic regressions were performed, accounting for age and AMD stage. RESULTS: Seventy-eight subjects (75.6% AMD; 24.4% controls) were included. Multivariate assessments revealed that body mass index (BMI; β = 0.30, P = 0.045), taking AREDS vitamins (β = 5.51, P < 0.001), and family history of AMD (β = 2.68, P = 0.039) were significantly associated with worse rod intercept times. Abnormal DA (rod intercept time ≥ 6.5 minutes) was significantly associated with family history of AMD (β = 1.84, P = 0.006), taking AREDS supplements (β = 1.67, P = 0.021) and alcohol intake (β = 0.07, P = 0.017). CONCLUSION: Besides age and AMD stage, a higher body mass index, higher alcohol intake, and a family history of AMD seem to impair DA. In this cohort, the use of AREDS vitamins was also statistically linked with impaired DA, most likely because of an increased severity of disease in subjects taking them.
PURPOSE: To determine the association between dark adaption (DA) and different health conditions linked with age-related macular degeneration (AMD). METHODS: Cross-sectional study, including patients with AMD and a control group. Age-related macular degeneration was graded according to the Age-Related Eye Disease Study (AREDS) classification. We obtained data on medical history, medications, and lifestyle. Dark adaption was assessed with the extended protocol (20 minutes) of AdaptDx (MacuLogix). For analyses, the right eye or the eye with more advanced AMD was selected. Multivariate linear and logistic regressions were performed, accounting for age and AMD stage. RESULTS: Seventy-eight subjects (75.6% AMD; 24.4% controls) were included. Multivariate assessments revealed that body mass index (BMI; β = 0.30, P = 0.045), taking AREDS vitamins (β = 5.51, P < 0.001), and family history of AMD (β = 2.68, P = 0.039) were significantly associated with worse rod intercept times. Abnormal DA (rod intercept time ≥ 6.5 minutes) was significantly associated with family history of AMD (β = 1.84, P = 0.006), taking AREDS supplements (β = 1.67, P = 0.021) and alcohol intake (β = 0.07, P = 0.017). CONCLUSION: Besides age and AMD stage, a higher body mass index, higher alcohol intake, and a family history of AMD seem to impair DA. In this cohort, the use of AREDS vitamins was also statistically linked with impaired DA, most likely because of an increased severity of disease in subjects taking them.
Authors: Ines Lains; Kevin M Mendez; João Q Gil; John B Miller; Rachel S Kelly; Patrícia Barreto; Ivana K Kim; Demetrios G Vavvas; Joaquim Neto Murta; Liming Liang; Rufino Silva; Joan W Miller; Jessica Lasky-Su; Deeba Husain Journal: J Clin Med Date: 2022-02-11 Impact factor: 4.241
Authors: Benjamin S Echols; Mark E Clark; Thomas A Swain; Ling Chen; Deepayan Kar; Yuhua Zhang; Kenneth R Sloan; Gerald McGwin; Ramya Singireddy; Christian Mays; David Kilpatrick; Jason N Crosson; Cynthia Owsley; Christine A Curcio Journal: Ophthalmol Retina Date: 2020-05-07
Authors: Inês Laíns; Daniela Duarte; António S Barros; Ana Sofia Martins; Tatiana J Carneiro; João Q Gil; John B Miller; Marco Marques; Tânia S Mesquita; Patrícia Barreto; Ivana K Kim; Maria da Luz Cachulo; Demetrios G Vavvas; Isabel M Carreira; Joaquim Neto Murta; Rufino Silva; Joan W Miller; Deeba Husain; Ana M Gil Journal: J Proteome Res Date: 2019-02-06 Impact factor: 4.466
Authors: Miin Roh; Hyun Joon Shin; Inês Laíns; Joana Providência; Maria Caseiro-Alves; Patrícia Barreto; Demetrios G Vavvas; John B Miller; Ivana K Kim; John Michael Gaziano; Liming Liang; Rufino Silva; Joan W Miller; Deeba Husain Journal: Invest Ophthalmol Vis Sci Date: 2020-02-07 Impact factor: 4.799
Authors: Kevin M Mendez; Janice Kim; Inês Laíns; Archana Nigalye; Raviv Katz; Shrinivas Pundik; Ivana K Kim; Liming Liang; Demetrios G Vavvas; John B Miller; Joan W Miller; Jessica A Lasky-Su; Deeba Husain Journal: Metabolites Date: 2021-03-21